Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Reiterates Hold on TrueCar

Needham Reiterates Hold on TrueCar

Needham analyst Chris Pierce reiterates TrueCar (NASDAQ:TRUE) with a Hold.

byBenzinga Newsdesk

February 23, 2023

1 minute read

Needham analyst Chris Pierce reiterates TrueCar (NASDAQ:TRUE) with a Hold.

Eli Lilly’s Diabetes Drug Shows Statistical Reduction In Blood Sugar Levels In Children, Adolescents

By Vandana Singh

December 7, 1:06 PM

Eli Lilly And Co’s (NYSE:LLY) DINAMO Phase 3 trial met its primary endpoint by demonstrating a statistically significant reduction in HbA1c…

LLY

Telsey Advisory Group Maintains Outperform on Torrid Holdings, Lowers Price Target to $8

By Benzinga Newsdesk

August 4, 5:23 AM

Telsey Advisory Group analyst Dana Telsey maintains Torrid Holdings (NYSE:CURV) with a Outperform and lowers the price target from $12 to $8.

CURV

Earnings Scheduled For August 1, 2022

By Benzinga Insights

August 1, 5:42 AM

Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.

ACT

ConocoPhillips (COP) Wins Approval To Develop Tommeliten Field

By Zacks

July 13, 11:32 AM

ConocoPhillips (NYSE: COP) received approval from the U.K. and Norway authorities for the development and operation of the Tommeliten A field in the North Sea.

COP

Needham Reiterates Hold on TrueCar

Related Posts

Eli Lilly’s Diabetes Drug Shows Statistical Reduction In Blood Sugar Levels In Children, Adolescents

Telsey Advisory Group Maintains Outperform on Torrid Holdings, Lowers Price Target to $8

Earnings Scheduled For August 1, 2022

ConocoPhillips (COP) Wins Approval To Develop Tommeliten Field